Blackstone Governance Rights
For so long as the Blackstone Purchasers hold 50% of the Series B Preferred Stock issued to them under the Blackstone SPA, the Blackstone Purchasers will have the right to nominate for election one member (the “Series B Director”) to the Board. The Blackstone SPA provides that the Blackstone Purchasers’ initial nominee to serve as Series B Director is David Blitzer, and that Mr. Blitzer will be elected to the Board immediately following the issuance of the Series B Preferred Stock.
Blackstone Standstill
Additionally, for so long as the Blackstone Purchasers have the right to nominate the Series B Director, the Blackstone Purchasers will be subject to certain standstill restrictions pursuant to which the Blackstone Purchasers will be restricted, among other things and subject to certain customary exceptions, from (i) acquiring additional equity securities or securities exchangeable for or convertible into equity securities of the Company; (ii) seeking representation on the Board (beyond their right to elect the Series B Director); (iii) seeking to change or influence the policies or management of the Company (beyond their right to elect the Series B Director); (iv) submitting any stockholder proposal to the Company; and (v) publicly proposing any change of control or other material transaction involving the Company; or supporting or encouraging any person in doing any of the foregoing.
The foregoing description of the terms of the Series B Preferred Stock, the Financing SPAs, the Certificate of Designation, the Registration Rights Agreement and the transactions contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Financing SPAs and the exhibits thereto, which are attached hereto as Exhibits 10.1 and 10.2, and are incorporated herein by reference.
The Financing SPAs have been filed to provide investors and securityholders with information regarding their terms and conditions. They are not intended to provide any other information about the Purchasers or the Company. The Financing SPAs contain representations, warranties, and covenants of the parties thereto made to and solely for the benefit of each other, and such representations, warranties, and covenants may be subject to materiality and other qualifiers applicable to the contracting parties that differ from those that may be viewed as material to investors. Accordingly, investors and securityholders should not rely on the representations, warranties, and covenants as characterizations of the actual state of facts. Moreover, information concerning the subject matter of the representations, warranties, and covenants may change after the date of the Financing SPAs, which subsequent information may or may not be fully reflected in the Company’s public disclosures.
This Current Report on Form 8-K does not constitute an offer to sell, or a solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Registrant.
The information related to the issuance and sale of Series B Preferred Stock contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
Item 3.02 Unregistered Sales of Equity Securities.
The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
As described in Item 1.01 of this Current Report on Form 8-K, under the terms of the Financing SPAs, the Company has agreed to issue shares of Series B Preferred Stock to the Purchasers at the Private Placement Closing. This issuance and sale will be exempt from registration under the Securities Act pursuant to Section 4(a)(2) thereof. The Financing SPAs contain representations of the Purchasers that each is an “accredited investor” as defined in Rule 501 under the Securities Act and that the shares of Series B Preferred Stock are being acquired for investment purposes and not with a view to or for sale in connection with any distribution thereof.
Item 3.03 Material Modification to the Rights of Securities Holders.
As described in Item 1.01 of this Current Report on Form 8-K, under the terms of the Financing SPAs, the Company has agreed to issue shares of Series B Preferred Stock to the Purchasers at the Private Placement Closing. The Certificate of Designations will entitle the Holders to certain rights that are senior to the rights of holders of the Common Stock and Series A Preferred Stock, such as rights to certain distributions and rights upon liquidation of the Company. In addition, in connection with the Private Placement Closing, the Company will enter into the